» Articles » PMID: 34094967

Radiotherapy and Cytokine Storm: Risk and Mechanism

Overview
Journal Front Oncol
Specialty Oncology
Date 2021 Jun 7
PMID 34094967
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Radiotherapy (RT) shows advantages as one of the most important precise therapy strategies for cancer treatment, especially high-dose hypofractionated RT which is widely used in clinical applications due to the protection of local anatomical structure and relatively mild impairment. With the increase of single dose, ranging from 2~20 Gy, and the decrease of fractionation, the question that if there is any uniform standard of dose limits for different therapeutic regimens attracts more and more attention, and the potential adverse effects of higher dose radiation have not been elucidated. In this study, the immunological adverse responses induced by radiation, especially the cytokine storm and the underlying mechanisms such as DAMPs release, pro-inflammatory cytokine secretion and cGAS-STING pathway activation, will be elucidated, which contributes to achieving optimal hypofractionated RT regimen, improving the killing of cancer cells and avoiding the severe side effects.

Citing Articles

Fluvastatin Promotes Treg Cell Production in Allogeneic Immune Reaction and Suppresses Inflammatory Response.

Chen X, Huang D, Zhao L, Tang D, Tian Y, Ren C Immun Inflamm Dis. 2025; 13(2):e70165.

PMID: 40007079 PMC: 11861029. DOI: 10.1002/iid3.70165.


Enhancing immunotherapy efficacy with synergistic low-dose radiation in metastatic melanoma: current insights and prospects.

Rafiq Z, Kang M, Barsoumian H, Manzar G, Hu Y, Leuschner C J Exp Clin Cancer Res. 2025; 44(1):31.

PMID: 39881333 PMC: 11781074. DOI: 10.1186/s13046-025-03281-2.


Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition.

Glaviano A, Lau H, Carter L, Lee E, Lam H, Okina E J Hematol Oncol. 2025; 18(1):6.

PMID: 39806516 PMC: 11733683. DOI: 10.1186/s13045-024-01634-6.


METTL3 inhibition promotes radiosensitivity in hepatocellular carcinoma through regulation of SLC7A11 expression.

Zhang C, Yang T, Chen H, Ding X, Chen H, Liang Z Cell Death Dis. 2025; 16(1):9.

PMID: 39799112 PMC: 11724875. DOI: 10.1038/s41419-024-07317-x.


Topkan's CARWL Index Efficiently Predicts the Radiation-Induced Tooth Loss Rates in Radically Treated Locally Advanced Nasopharyngeal Cancer Patients.

Somay E, Topkan E, Bascil S, Ozturk D, Senyurek S, Durankus N Technol Cancer Res Treat. 2024; 23:15330338241292234.

PMID: 39420731 PMC: 11490988. DOI: 10.1177/15330338241292234.


References
1.
Joo H, Hong E, Cho S, Nam S, Kim J . Preventative and Therapeutic Effects of Low-dose Ionizing Radiation on the Allergic Response of Rat Basophilic Leukemia Cells. Sci Rep. 2019; 9(1):16079. PMC: 6834612. DOI: 10.1038/s41598-019-52399-9. View

2.
Hill G, Ferrara J . The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation. Blood. 2000; 95(9):2754-9. View

3.
Jarosz-Biej M, Smolarczyk R, Cichon T, Kulach N . Tumor Microenvironment as A "Game Changer" in Cancer Radiotherapy. Int J Mol Sci. 2019; 20(13). PMC: 6650939. DOI: 10.3390/ijms20133212. View

4.
Bernstein M, Krishnan S, Hodge J, Chang J . Immunotherapy and stereotactic ablative radiotherapy (ISABR): a curative approach?. Nat Rev Clin Oncol. 2016; 13(8):516-24. PMC: 6053911. DOI: 10.1038/nrclinonc.2016.30. View

5.
Hu Z, McArthur H, Ho A . The Abscopal Effect of Radiation Therapy: What Is It and How Can We Use It in Breast Cancer?. Curr Breast Cancer Rep. 2017; 9(1):45-51. PMC: 5346418. DOI: 10.1007/s12609-017-0234-y. View